JM

James Mackay

CEO

Nuvig Therapeutics Inc.

San Diego, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Nuvig Therapeutics Inc.
Industry
research
Employees
26.0
Seniority
C suite
Annual Revenue
3000000.0
Total Funding
208000000.0
Latest Funding
Series B

Technologies

Mimecast Outlook Microsoft Office 365 Google Tag Manager WordPress.org Mobile Friendly reCAPTCHA AI

Keywords

biotechnology research autoimmune therapies immune modulators chronic inflammatory diseases next-generation immunotherapy novel therapeutics fc receptor targeting biologics immunomodulation nuvig therapeutics nvg-2089 chronic inflammatory demyelinating polyneuropathy cidp treatment sialylated igg immune function rebalancing anti-inflammatory effects fda fast track designation clinical development recombinant protein therapy therapeutic area development bi & tri-functional antibodies immuno-oncology quality of life improvement biotech industry pipeline advancement therapeutic innovation t regulatory cell expansion autoimmune disease management safety & tolerability studies preclinical engineering immune regulation immune dysregulation ivig limitations biotech collaborations clinical program design investigational new drug internal talent acquisition scientific collaboration biotech financing clinical proof-of-concept patient-focused therapies translational medicine evidence-based medicine biotech partnerships disease burden chronic disease treatment therapeutic strategies patient outcomes

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans